December 5, 2008 - Fri
Browse trough Articles, Archives otherwise use Site Search

Site Search:

« PreviousNext »

  • Register
  • Login
  • World Cancer Congress with the theme of “From Basic Research to Therapeutics”

  • Posted by Administrator on 25 February 2008
  • June 12-17 in Shanghai

    BIT Life Sciences is proud to announce that World Cancer Congress with the theme of
    “From Basic Research to Therapeutics, will be held during June 12-17 in Shanghai, the
    “Pearl of China” as the largest and most prosperous city in China.

    More than 600 overseas cancer specialists from a wide range of disciplines will
    participate in the scientific program and their presentations will provide delegates with
    information on the latest developments in basic and clinical research. We propose to
    establish a technological and informative campaign as an echo to global anti-cancer
    action. Up to date, the upcoming “From Basic Research to Therapeutics” of World
    Cancer Congress has already made positive waves in the cancer research with its
    detailed and informative program with subjects delivered by highly respected speakers.
    For example:

    Dr. Andrew V. Schally, Professor, Veterans Affairs, The Nobel Prize in Physiology or
    Medicine 1977, USA
    Dr. Elwood V. Jensen, Distinguished Professor, University of Cincinnati, 2004 Albert
    Lasker Medical Award Winner, USA
    Dr. Francis P. Crawley, Executive Director, Good Clinical Practice Alliance – Europe;
    Expert in ethics of World Health Organization, Belgium
    Dr. Alan Garen, Professor, Yale University, Member, National Academy of Sciences,
    USA
    Dr. David Vesely, Professor, Chief of Endocrinology, US Department of Veterans
    Affairs, James A. Halley VA Medical Center, USA
    Dr. Samir N. Khleif, Senior investigator and Chief of Cancer Vaccine Section at the NCI,
    USA
    Dr. Stephen D. Barnhill, Chairman and Chief Executive Officer, Health Discovery
    Corporation, USA
    Dr. Iqbal S. Grewal, Vice President, Preclinical Therapeutics, Seattle Genetics, Inc.,
    USA

    The above list is only a small sample of what is available at this conference. I attached
    the Preliminary Program at the bottom of the letter (Further information can be found
    at our website: http://www.bitlifesciences.com/cancer2008/Program.htm )

    We welcome the attendees to meet the renowned speakers and share your knowledge
    with them in cancer field. Register on-line through website: http://www.bitlifesciences.
    com/cancer2008/Registration-now.htm for this event, or call BIT Life Sciences
    directly at 0086-411-84799479 and ask for Registration.

    With only a few slots remaining, we sincerely hope you could take advantage of the
    opportunity to participate in our upcoming World Cancer Congress. If you would like
    to submit a proposal to give a presentation at this meeting, please submit a title and
    brief summary (3-5 sentences) on your recent work in the topics mentioned. Please
    indicate which session you are most interested in giving a speech after viewing our
    program. To ensure the quality of the program, all proposals will be reviewed by the
    Scientific Advisory Committee.

    Topics may include, but are not limited to:
    * Frontier of Basic Oncology Research: Leading Waves of Omics
    * Molecular & Cell Biology in Oncology
    * Molecular Oncology
    * Cancer Pathology
    * Neuro-oncology
    * Hematology-Oncology
    * Cancer Endocrinology
    * Cancer Epidemiology and Cancer Surveillance
    * Basic and Translational Research of Cancer Microenvironment
    * Tumor Immunology and Immunotherapy
    * Tumor Virology
    * Better Understanding Carcinogenesis: Breast, Lung and Stomach Cancers, Other
    Cancers and Melanoma
    * Post-Genome Cutting-Edge Molecular Approaches to Therapeutics
    * Druggable Biomarkers , Target Validations and High Throughput Screening
    * Small Molecule Anti-Cancer Drug Discovery: Bioinformatics, Rational Drug Design nd
    Lead Optimizations
    * Hunting for Bio-Gateway: From Protein, Monoclonal Antibodies to Vaccines
    * RNAi, siRNA, mRNA and Gene Therapy for Carcinomas
    * Cell Therapeutics Discovery and Development
    * Angiogenesis and Anti-Angiogenesis Therapeutic Development
    * Better Drug Delivery Systems for Anti-Cancer Molecules
    * Tumor Animal Models for Development of New Therapeutic Strategies
    * Putting Launched Novel Drugs into Practice
    * Latest Technical Developments in Cancer Diagnosis/Prognosis and Clinical Practice
    * New Research and Expanded Treatment for Cancer: Chemotherapy, Bio-therapy,
    Hadron-therapy and Surgical Treatment
    * Personalized Treatment and Targeted Cancer Therapeutics
    * Traditional Chinese Medicine, Complementary Therapies and Nutritional Protection
    * Liver Cancer
    * Cancer Invasion and Metastasis
    * Breast Cancer
    * Cancer Imaging: MRI, PET and Molecular Imaging
    * Integration of Biology, Physics and Technology in Clinical Radiation Oncology
    * Future Drugs: Breakthrough of Worldwide Late-Stage Anti-Cancer
    * Investment on Early and Late Phase Anti-Cancer Drug Development
    * Public and Private Research Funding Opportunities
    * Efficient Marketing Channels and Health Insurance System Synergy
    * Effective Methods in Clinical Cancer Research
    * Pathobiology and Biostatistics of Cancers
    * Nursing Care, Survivorship vs Palliative Cares of Cancer Patients

    Call for Posters: Your research will be seen by a cross section of scientists and leaders
    from top academic, healthcare, pharmaceutical, and biotech institutes

    We welcome the speakers, attendees, and sponsor to make a registration on
    http://www.bitlifesciences.com/cancer2008/Registration-now.htm

    We look forward to seeing you in Shanghai, China!
    Yours Faithfully,
    Kevin Li
    Program Coordinator
    Organizing Committee of the World Cancer Congress
    26 Gaoneng St., R401
    Dalian Hightech Zone
    Dalian, LN 116025, China
    Tel: 0086-411-84799479
    Fax: 0086-411-84799629
    Email: kevin@bitlifesciences.com

    Filed under Cancers | Trackback | Top Of Page

    Leave a reply

    You must be logged in to post a comment.

    Latest Articles and Events:

    Links

    Categories

    Topic Discussion

    Archives

    Rss Feed

    Recent Comments